7603 related articles for article (PubMed ID: 23354891)
21. Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer.
Brevi A; Cogrossi LL; Grazia G; Masciovecchio D; Impellizzieri D; Lacanfora L; Grioni M; Bellone M
Front Immunol; 2020; 11():565470. PubMed ID: 33244315
[TBL] [Abstract][Full Text] [Related]
22. Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.
Hannani D; Vétizou M; Enot D; Rusakiewicz S; Chaput N; Klatzmann D; Desbois M; Jacquelot N; Vimond N; Chouaib S; Mateus C; Allison JP; Ribas A; Wolchok JD; Yuan J; Wong P; Postow M; Mackiewicz A; Mackiewicz J; Schadendorff D; Jaeger D; Zörnig I; Hassel J; Korman AJ; Bahjat K; Maio M; Calabro L; Teng MW; Smyth MJ; Eggermont A; Robert C; Kroemer G; Zitvogel L
Cell Res; 2015 Feb; 25(2):208-24. PubMed ID: 25582080
[TBL] [Abstract][Full Text] [Related]
23. Increased IL-17A/IL-17F expression ratio represents the key mucosal T helper/regulatory cell-related gene signature paralleling disease activity in ulcerative colitis.
Iboshi Y; Nakamura K; Fukaura K; Iwasa T; Ogino H; Sumida Y; Ihara E; Akiho H; Harada N; Nakamuta M
J Gastroenterol; 2017 Mar; 52(3):315-326. PubMed ID: 27178567
[TBL] [Abstract][Full Text] [Related]
24. [Eustachian orifice malignant melanoma: a case report].
Su Z; Wu W; Pan J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Feb; 27(4):221-2. PubMed ID: 23631145
[TBL] [Abstract][Full Text] [Related]
25. TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone.
Martiniuk F; Damian DL; Thompson JF; Scolyer RA; Tchou-Wong KM; Levis WR
J Drugs Dermatol; 2010 Nov; 9(11):1368-72. PubMed ID: 21061759
[TBL] [Abstract][Full Text] [Related]
26. Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosis.
Robak E; Gerlicz-Kowalczuk Z; Dziankowska-Bartkowiak B; Wozniacka A; Bogaczewicz J
Arch Med Sci; 2019 May; 15(3):706-712. PubMed ID: 31110538
[TBL] [Abstract][Full Text] [Related]
27. Different T cell subsets in the nodule and synovial membrane: absence of interleukin-17A in rheumatoid nodules.
Stamp LK; Easson A; Lehnigk U; Highton J; Hessian PA
Arthritis Rheum; 2008 Jun; 58(6):1601-8. PubMed ID: 18512780
[TBL] [Abstract][Full Text] [Related]
28. Synovial sarcoma of the Eustachian tube.
Lin HC; Friedman M; Kuo FY; Huang HY
Head Neck; 2009 Sep; 31(9):1245-8. PubMed ID: 19132715
[TBL] [Abstract][Full Text] [Related]
29. Increased Expression of IL-17A and IL-17F Is Correlated With RUNX1 and RORγT in Pediatric Patients With Primary Immune Thrombocytopenia.
Elnaenaey WA; Omar OM; Aboelwafa RA
J Pediatr Hematol Oncol; 2021 Apr; 43(3):e320-e327. PubMed ID: 33633027
[TBL] [Abstract][Full Text] [Related]
30. Malignant melanoma of the eustachian tube.
Lai CC; Tsay SH; Ho CY
J Laryngol Otol; 2001 Jul; 115(7):567-9. PubMed ID: 11485591
[TBL] [Abstract][Full Text] [Related]
31. A Rare Instance of Primary Oncocytic Schneiderian Papilloma of Middle Ear and Eustachian Tube With a Combined Trans Oto and Nasal Approach Resection.
Fu ZM; Zhao LP; Guo YY; Guan GF
J Craniofac Surg; 2020; 31(2):504-506. PubMed ID: 31977707
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory responses induced by interleukin-17 family members in human colonic subepithelial myofibroblasts.
Yagi Y; Andoh A; Inatomi O; Tsujikawa T; Fujiyama Y
J Gastroenterol; 2007 Sep; 42(9):746-53. PubMed ID: 17876544
[TBL] [Abstract][Full Text] [Related]
33. The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases.
Pappu R; Ramirez-Carrozzi V; Sambandam A
Immunology; 2011 Sep; 134(1):8-16. PubMed ID: 21726218
[TBL] [Abstract][Full Text] [Related]
34. IL-17 in the immunopathogenesis of spondyloarthritis.
Taams LS; Steel KJA; Srenathan U; Burns LA; Kirkham BW
Nat Rev Rheumatol; 2018 Aug; 14(8):453-466. PubMed ID: 30006601
[TBL] [Abstract][Full Text] [Related]
35. Chlamydophila pneumoniae re-infection triggers the production of IL-17A and IL-17E, important regulators of airway inflammation.
Mosolygó T; Korcsik J; Balogh EP; Faludi I; Virók DP; Endrész V; Burián K
Inflamm Res; 2013 May; 62(5):451-60. PubMed ID: 23385305
[TBL] [Abstract][Full Text] [Related]
36. TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma.
Xiao W; Du N; Huang T; Guo J; Mo X; Yuan T; Chen Y; Ye T; Xu C; Wang W; Wang G; Cai S; Chen J
EBioMedicine; 2018 Jun; 32():119-124. PubMed ID: 29793878
[TBL] [Abstract][Full Text] [Related]
37. Wandering Mucosal Melanoma Presenting as Occult Gastrointestinal Blood Loss Anemia.
Farooq A; Rahman H; Bani Fawwaz BA; Hurairah A
Cureus; 2022 Jun; 14(6):e25614. PubMed ID: 35795509
[TBL] [Abstract][Full Text] [Related]
38. Mucoepidermoid carcinoma arising from the eustachian tube and middle ear.
Kim YH; Chae SW; Jung HH
J Laryngol Otol; 2003 Mar; 117(3):202-4. PubMed ID: 12648377
[TBL] [Abstract][Full Text] [Related]
39. IL-17C/IL-17 Receptor E Signaling in CD4
Krohn S; Nies JF; Kapffer S; Schmidt T; Riedel JH; Kaffke A; Peters A; Borchers A; Steinmetz OM; Krebs CF; Turner JE; Brix SR; Paust HJ; Stahl RAK; Panzer U
J Am Soc Nephrol; 2018 Apr; 29(4):1210-1222. PubMed ID: 29483158
[TBL] [Abstract][Full Text] [Related]
40. IL-17 inhibitors for psoriasis.
Paek SY; Frieder J; Kivelevitch D; Menter MA
Semin Cutan Med Surg; 2018 Sep; 37(3):148-157. PubMed ID: 30215631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
